212 related articles for article (PubMed ID: 32118741)
1. No-reflow phenomenon during percutaneous coronary intervention in a patient with polycythemia vera: A case report.
Oktaviono YH; Hutomo SA; Al-Farabi MJ
Medicine (Baltimore); 2020 Feb; 99(9):e19288. PubMed ID: 32118741
[TBL] [Abstract][Full Text] [Related]
2. No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.
Gupta S; Gupta MM
Indian Heart J; 2016; 68(4):539-51. PubMed ID: 27543480
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
[TBL] [Abstract][Full Text] [Related]
4. Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction.
Schram HCF; Hemradj VV; Hermanides RS; Kedhi E; Ottervanger JP;
Int J Cardiol; 2018 Aug; 265():12-17. PubMed ID: 29731349
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
7. Administration of intracoronary adenosine before stenting for the prevention of no-reflow in patients with ST-elevation myocardial infarction.
Sadeghian M; Mousavi SH; Aamaraee Z; Shafiee A
Scand Cardiovasc J; 2022 Dec; 56(1):23-27. PubMed ID: 35253571
[No Abstract] [Full Text] [Related]
8. Renal Dysfunction as a Predictor of Slow-Flow/No-Reflow Phenomenon and Impaired ST Segment Resolution After Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction With Initial Thrombolysis in Myocardial Infarction Grade 0.
Kai T; Oka S; Hoshino K; Watanabe K; Nakamura J; Abe M; Watanabe A
Circ J; 2021 Sep; 85(10):1770-1778. PubMed ID: 34305099
[TBL] [Abstract][Full Text] [Related]
9. Is Atherothromboaspiration a Possible Solution for the Prevention of No-Reflow Phenomenon in Acute Coronary Syndromes? Single Centre Experience and Review of the Literature.
Manolis AS
Curr Vasc Pharmacol; 2019; 17(2):164-179. PubMed ID: 29298651
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of the No-Reflow Group After Primary Percutaneous Coronary Intervention Due to ST-Segment Elevation Myocardial Infarction - Are There Sex Differences?
Zachura M; Sadowski M; Kurzawski J; Piątek K; Gąsior M
Cardiovasc Revasc Med; 2022 Apr; 37():97-101. PubMed ID: 34167912
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).
Carrick D; Oldroyd KG; McEntegart M; Haig C; Petrie MC; Eteiba H; Hood S; Owens C; Watkins S; Layland J; Lindsay M; Peat E; Rae A; Behan M; Sood A; Hillis WS; Mordi I; Mahrous A; Ahmed N; Wilson R; Lasalle L; Généreux P; Ford I; Berry C
J Am Coll Cardiol; 2014 May; 63(20):2088-2098. PubMed ID: 24583294
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study.
Ma M; Wang L; Diao KY; Liang SC; Zhu Y; Wang H; Wang M; Zhang L; Yang ZG; He Y
BMC Cardiovasc Disord; 2022 Feb; 22(1):30. PubMed ID: 35120436
[TBL] [Abstract][Full Text] [Related]
14. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
[TBL] [Abstract][Full Text] [Related]
15. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Quisi A; Alıcı G
J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
[TBL] [Abstract][Full Text] [Related]
16. Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Refaat H; Tantawy A; Gamal AS; Radwan H
Indian Heart J; 2021; 73(1):35-43. PubMed ID: 33714407
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis.
Wang L; Huang S; Zhou Q; Dou L; Lin D
Clin Cardiol; 2024 Feb; 47(2):e24238. PubMed ID: 38400562
[TBL] [Abstract][Full Text] [Related]
18. The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Somuncu MU; Akgun T; Cakır MO; Akgul F; Serbest NG; Karakurt H; Can M; Demir AR
J Atheroscler Thromb; 2019 Nov; 26(11):970-978. PubMed ID: 30996145
[TBL] [Abstract][Full Text] [Related]
19. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
20. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction.
Balta S; Celik T; Ozturk C; Kaya MG; Aparci M; Yildirim AO; Demir M; Kilic S; Aydin İ; Iyisoy A
Am J Emerg Med; 2016 Aug; 34(8):1542-7. PubMed ID: 27238848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
